Luigi Mangione made a confession in court last Friday, acknowledging that he had fatally shot Brian Thompson, a health insurance executive. He pleaded guilty to two federal charges related to stalking Thompson with the intention to kill him. Mangione, donning beige prison attire, spoke calmly as he admitted to the shooting, highlighting his discontent with the U.S. health insurance system in a prepared statement.
Thompson’s widow and family members were present in the courtroom. Mangione’s admission led to an emotional moment for Thompson’s widow, who was comforted by those around her. The guilty plea by Mangione resolved the need for a federal trial in the widely followed case involving the killing of the UnitedHealthcare CEO, which stirred public outrage and symbolized widespread frustration with the practices of the health insurance industry.
At 28 years old, Mangione entered the plea without any agreement with federal prosecutors, leaving the sentencing outcome uncertain. Prosecutors indicated their intent to seek the maximum penalty of life imprisonment during Mangione’s sentencing scheduled for December 18. U.S. District Judge Margaret Garnett may take into account Mangione’s guilty plea as a mitigating factor in determining his punishment.
The guilty plea also allowed Mangione’s legal team to request the dismissal of separate state charges for murder and weapons possession, arguing against being penalized twice for the same offense under New York’s double jeopardy law. Manhattan U.S. Attorney Jamie McDonald emphasized that no concessions were made to Mangione by his office and reiterated that no cause or belief justifies murder.
Thompson’s family expressed that the guilty plea marked a significant step towards justice and called for a sentencing reflecting the gravity of the crime. Thompson, who led UnitedHealth Group’s insurance division, was shot and killed outside a hotel during an investor conference in December 2024. The case gained widespread media attention due to graphic footage of the incident and the subsequent manhunt that led to Mangione’s arrest in Pennsylvania.
In his statement, Mangione mentioned facing obstacles with his insurance after a back injury without elaborating further. He detailed how he impersonated an investor managing substantial assets to obtain information about UnitedHealthcare’s investor conference and then used a 3D printer to create a component of a gun with the intent to kill Thompson. UnitedHealth Group expressed gratitude to law enforcement for apprehending Thompson’s killer.
Mangione had previously pleaded not guilty to federal murder, weapons, and stalking charges, which were dismissed due to legal technicalities in January 2026. In a separate state case, Mangione pleaded not guilty to terrorism, murder, weapons, and forgery charges. The trial for the state case is set for September 8, where Mangione could face a lengthy prison sentence if convicted of second-degree murder.
As Mangione’s lawyers seek to dismiss the state case under double jeopardy laws, the Manhattan District Attorney’s Office remains prepared to contest the motion, affirming their commitment to seeking justice for Thompson and his family. The complexity of the case and the legal arguments surrounding it indicate potential challenges in moving forward with the trial, as legal experts debate the nuances between the stalking and murder charges.